<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04633629</url>
  </required_header>
  <id_info>
    <org_study_id>38RC20.328</org_study_id>
    <secondary_id>2020-A02413-36</secondary_id>
    <nct_id>NCT04633629</nct_id>
  </id_info>
  <brief_title>LUS in Acute Heart Failure Therapeutic Adaptation</brief_title>
  <acronym>EPPICA</acronym>
  <official_title>Interest of Lung Ultrasound (LUS) in Therapeutic Adaptation of Patients Hospitalized in Medical Department for Acute Heart Failure (AHF).</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Grenoble</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Grenoble</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluate lung ultrasound aspect according to diuretics dosage evolution in patients&#xD;
      hospitalized for acute heart failure.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      EPPICA is an observational and prospective cohort study. The study goal is to evaluate LUS&#xD;
      aspect evolution according to diuretics dosage in patients hospitalized for acute heart&#xD;
      failure.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 2020</start_date>
  <completion_date type="Anticipated">October 2021</completion_date>
  <primary_completion_date type="Anticipated">May 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Lung ultrasound aspect according to diuretics dosage evolution.</measure>
    <time_frame>LUS will be performed daily during the whole hospitalisation length (on average 7 days).</time_frame>
    <description>B-lines number on LUS</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Lung ultrasound aspect according to clinical signs of acute heart failure (crackling auscultation or lower limbs edema)</measure>
    <time_frame>LUS and clinical examination will be performed daily during the whole hospitalisation length (on average 7 days).</time_frame>
    <description>B-lines number on LUS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lung ultrasound aspect according to acute kidney injury (based on plasmatic creatinine levels).</measure>
    <time_frame>LUS will be performed daily during the whole hospitalisation length (on average 7 days). Plasmatic creatinine measure will be performed at least weekly.</time_frame>
    <description>B-lines number on LUS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lung ultrasound aspect according to early prognosis (re-hospitalisation or mortality within 30 days after discharge)</measure>
    <time_frame>LUS will be performed daily during the whole hospitalisation length (on average 7 days). Patient will be called 30 days after discharge.</time_frame>
    <description>B-lines number on LUS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Feasibility of daily LUS in medical department.</measure>
    <time_frame>LUS will be performed daily during the whole hospitalisation length (on average 7 days).</time_frame>
    <description>Number of LUS performed compared to number of hospitalisation days.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Interest of LUS compared to clinical examination at discharge.</measure>
    <time_frame>LUS and clinical examination will be performed daily during the whole hospitalisation length (on average 7 days).</time_frame>
    <description>B-lines at discharge compared to clinical signs of acute heart failure.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">94</enrollment>
  <condition>Acute Heart Failure</condition>
  <condition>Pulmonary Congestion</condition>
  <arm_group>
    <arm_group_label>Patients with acute heart failure</arm_group_label>
    <description>Patients hospitalized for acute heart failure in medical department.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Lung ultrasound</intervention_name>
    <description>We will perform daily a lung ultrasound to evaluate pulmonary congestion by counting B-lines.</description>
    <arm_group_label>Patients with acute heart failure</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients aged over 18, hospitalized from the emergency department in the medical department&#xD;
        for acute heart failure.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Acute heart failure diagnosed by a senior physician in the medical department, with a&#xD;
             confirmation of a second senior physician.&#xD;
&#xD;
          -  Hospitalised in the medical department.&#xD;
&#xD;
          -  No objection from the patient of his trusted person.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Administrative supervision or deprived of their liberty&#xD;
&#xD;
          -  Pulmonary conditions distracting lung ultrasound (pneumonectomy, pulmonary fibrosis)&#xD;
&#xD;
          -  Chronically dialysed&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Perrine Dumanoir, Doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Grenoble</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Perrine Dumanoir, Doctor</last_name>
    <phone>+33476767098</phone>
    <email>pdumanoir@chu-grenoble.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mélanie Arnaud</last_name>
    <phone>+3376767098</phone>
    <email>marnaud3@chu-grenoble.fr</email>
  </overall_contact_backup>
  <reference>
    <citation>Öhman J, Harjola VP, Karjalainen P, Lassus J. Focused echocardiography and lung ultrasound protocol for guiding treatment in acute heart failure. ESC Heart Fail. 2018 Feb;5(1):120-128. doi: 10.1002/ehf2.12208. Epub 2017 Sep 28.</citation>
    <PMID>28960894</PMID>
  </reference>
  <reference>
    <citation>Coiro S, Rossignol P, Ambrosio G, Carluccio E, Alunni G, Murrone A, Tritto I, Zannad F, Girerd N. Prognostic value of residual pulmonary congestion at discharge assessed by lung ultrasound imaging in heart failure. Eur J Heart Fail. 2015 Nov;17(11):1172-81. doi: 10.1002/ejhf.344. Epub 2015 Sep 29.</citation>
    <PMID>26417699</PMID>
  </reference>
  <reference>
    <citation>Gargani L, Pang PS, Frassi F, Miglioranza MH, Dini FL, Landi P, Picano E. Persistent pulmonary congestion before discharge predicts rehospitalization in heart failure: a lung ultrasound study. Cardiovasc Ultrasound. 2015 Sep 4;13:40. doi: 10.1186/s12947-015-0033-4.</citation>
    <PMID>26337295</PMID>
  </reference>
  <reference>
    <citation>Platz E, Merz AA, Jhund PS, Vazir A, Campbell R, McMurray JJ. Dynamic changes and prognostic value of pulmonary congestion by lung ultrasound in acute and chronic heart failure: a systematic review. Eur J Heart Fail. 2017 Sep;19(9):1154-1163. doi: 10.1002/ejhf.839. Epub 2017 May 30. Review.</citation>
    <PMID>28557302</PMID>
  </reference>
  <reference>
    <citation>Volpicelli G, Caramello V, Cardinale L, Mussa A, Bar F, Frascisco MF. Bedside ultrasound of the lung for the monitoring of acute decompensated heart failure. Am J Emerg Med. 2008 Jun;26(5):585-91. doi: 10.1016/j.ajem.2007.09.014.</citation>
    <PMID>18534289</PMID>
  </reference>
  <reference>
    <citation>Rusu DM, Siriopol I, Grigoras I, Blaj M, Ciumanghel AI, Siriopol D, Nistor I, Onofriescu M, Sandu G, Cobzaru B, Scripcariu DV, Diaconu O, Covic AC. Lung Ultrasound Guided Fluid Management Protocol for the Critically Ill Patient: study protocol for a multi-centre randomized controlled trial. Trials. 2019 Apr 25;20(1):236. doi: 10.1186/s13063-019-3345-0.</citation>
    <PMID>31023358</PMID>
  </reference>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>September 8, 2020</study_first_submitted>
  <study_first_submitted_qc>November 12, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 18, 2020</study_first_posted>
  <last_update_submitted>November 12, 2020</last_update_submitted>
  <last_update_submitted_qc>November 12, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Lung Ultrasound</keyword>
  <keyword>Diuretics</keyword>
  <keyword>Medical department</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

